ACCESS PACK EXPO XPRESS ONLINE TODAY
ACCESS PACK EXPO XPRESS ONLINE TODAY. Content is available on-demand through November 30th.
LEARN MORE

OTC COVID-19 Test Gets FDA Emergency Use Authorization

The DETECT™ test will be the lowest priced PCR-quality test available for use at home.

A recent businesswire article discussed the latest product to receive the FDA’s coveted emergency use authorization. The Detect COVID-19 test from Detect™, Inc. will be available for over-the-counter home use in the coming weeks. The cost will be under $50, which makes it the lowest priced at-home molecular test available to consumers. The test will also be used for regular screening programs in school and workplaces.

The Detect test is meant to work in unison with a proprietary app that gives users instructions on how to perform the test and interpret their results. Detect is also developing an electronic travel pass system with an add-on telehealth service so that their test may be used for travel and event entry. As a vote of confidence, Detect received an $8.1 million contract to increase manufacturing from the NIH Rapid Acceleration of Diagnostics Initiative.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts
Access On-Demand Content Today
Discover innovative solutions for packaging and processing, automation, sustainability, e-commerce and more.
LEARN MORE
Access On-Demand Content Today